Literature DB >> 19911821

Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins.

Alfonso Maresca1, Claudia Temperini, Lionel Pochet, Bernard Masereel, Andrea Scozzafava, Claudiu T Supuran.   

Abstract

Coumarin derivatives were recently shown to constitute a totally new class of inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), being hydrolyzed within the CA active site to 2-hydroxycinnamic acids. We explore here a new series of variously substituted coumarins and a thiocoumarin for their interaction with 13 mammalian CA isoforms, detecting low nanomolar and isoform selective inhibitors. The mechanism of action of this class of inhibitors is delineated in detail by resolving the X-ray crystal structure of CA II in complex with trans-2-hydroxy-cinnamic acid, the in situ hydrolysis product of simple coumarin. Thiocoumarins also act as efficient CAIs, similarly to coumarins. The versatility of the (thio)coumarin chemistry, the cis-trans isomerization evidenced here, and easy derivatization of the (thio)coumarin rings, coupled with the nanomolar inhibition range of several isozymes, afford isoform-selective CAIs with various biomedical applications, which render these classes of compounds superior to the clinically used sulfonamides.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19911821     DOI: 10.1021/jm901287j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  61 in total

1.  Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo.

Authors:  Fabrizio Carta; Mayank Aggarwal; Alfonso Maresca; Andrea Scozzafava; Robert McKenna; Emanuela Masini; Claudiu T Supuran
Journal:  J Med Chem       Date:  2012-02-13       Impact factor: 7.446

2.  Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.

Authors:  David P Martin; Seth M Cohen
Journal:  Chem Commun (Camb)       Date:  2012-04-24       Impact factor: 6.222

3.  Bidentate Zinc chelators for alpha-carbonic anhydrases that produce a trigonal bipyramidal coordination geometry.

Authors:  Johannes Schulze Wischeler; Alessio Innocenti; Daniela Vullo; Arpita Agrawal; Seth M Cohen; Andreas Heine; Claudiu T Supuran; Gerhard Klebe
Journal:  ChemMedChem       Date:  2010-09-03       Impact factor: 3.466

4.  Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations.

Authors:  Jason Wagner; Balendu Sankara Avvaru; Arthur H Robbins; Andrea Scozzafava; Claudiu T Supuran; Robert McKenna
Journal:  Bioorg Med Chem       Date:  2010-06-15       Impact factor: 3.641

Review 5.  Interfering with pH regulation in tumours as a therapeutic strategy.

Authors:  Dario Neri; Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2011-09-16       Impact factor: 84.694

6.  α-Carbonic Anhydrases Possess Thioesterase Activity.

Authors:  Muhammet Tanc; Fabrizio Carta; Andrea Scozzafava; Claudiu T Supuran
Journal:  ACS Med Chem Lett       Date:  2015-01-19       Impact factor: 4.345

7.  Design, synthesis, in silico and biological evaluation of novel 2-(4-(4-substituted piperazin-1-yl)benzylidene)hydrazine carboxamides.

Authors:  Shikha Kumari; Chandra Bhushan Mishra; Danish Idrees; Amresh Prakash; Rajesh Yadav; Md Imtaiyaz Hassan; Manisha Tiwari
Journal:  Mol Divers       Date:  2016-12-30       Impact factor: 2.943

Review 8.  An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities.

Authors:  Francesca Annunziata; Cecilia Pinna; Sabrina Dallavalle; Lucia Tamborini; Andrea Pinto
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923

9.  Inhibition of carbonic anhydrase IX as a novel anticancer mechanism.

Authors:  Claudiu T Supuran
Journal:  World J Clin Oncol       Date:  2012-07-10

10.  Advances in Anti-Cancer Drug Development Targeting Carbonic Anhydrase IX and XII.

Authors:  Mam Y Mboge; Robert McKenna; Susan C Frost
Journal:  Top Anticancer Res       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.